USD 1.0
(-3.68%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 12.63 Million USD | 5.32% |
2023 | 11.99 Million USD | 10.56% |
2022 | 10.84 Million USD | -33.6% |
2021 | 16.33 Million USD | 63.4% |
2020 | 9.99 Million USD | 594.37% |
2019 | 1.44 Million USD | 7.55% |
2018 | 1.33 Million USD | 2.04% |
2017 | 1.31 Million USD | 150.09% |
2016 | 524.7 Thousand USD | 1230.33% |
2015 | 39.44 Thousand USD | 277.33% |
2014 | 10.45 Thousand USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q4 | 12.63 Million USD | -4.24% |
2024 Q3 | 13.19 Million USD | 1.48% |
2024 Q2 | 13 Million USD | 0.27% |
2024 Q1 | 12.96 Million USD | 8.1% |
2023 Q3 | 13.63 Million USD | 5.31% |
2023 Q2 | 12.95 Million USD | 0.61% |
2023 Q4 | 11.99 Million USD | -12.04% |
2023 Q1 | 12.87 Million USD | 18.64% |
2023 FY | 11.99 Million USD | 10.56% |
2022 Q1 | 16.31 Million USD | -0.15% |
2022 FY | 10.84 Million USD | -33.6% |
2022 Q4 | 10.84 Million USD | -21.9% |
2022 Q3 | 13.89 Million USD | -16.11% |
2022 Q2 | 16.55 Million USD | 1.5% |
2021 Q4 | 16.33 Million USD | -1.43% |
2021 FY | 16.33 Million USD | 63.4% |
2021 Q1 | 11.47 Million USD | 14.8% |
2021 Q2 | 6.57 Million USD | -42.76% |
2021 Q3 | 16.57 Million USD | 152.25% |
2020 Q2 | 2.49 Million USD | 80.47% |
2020 Q3 | 3.85 Million USD | 54.69% |
2020 FY | 9.99 Million USD | 594.37% |
2020 Q4 | 9.99 Million USD | 159.41% |
2020 Q1 | 1.38 Million USD | -4.12% |
2019 Q1 | 1.31 Million USD | -2.16% |
2019 FY | 1.44 Million USD | 7.55% |
2019 Q3 | 1.53 Million USD | -6.98% |
2019 Q4 | 1.44 Million USD | -5.88% |
2019 Q2 | 1.64 Million USD | 25.55% |
2018 FY | 1.33 Million USD | 2.04% |
2018 Q4 | 1.33 Million USD | 51.5% |
2018 Q2 | 1.37 Million USD | 17.81% |
2018 Q1 | 1.17 Million USD | -10.74% |
2018 Q3 | 883.82 Thousand USD | -35.95% |
2017 Q3 | 208.19 Thousand USD | -52.57% |
2017 Q2 | 438.96 Thousand USD | -25.01% |
2017 FY | 1.31 Million USD | 150.09% |
2017 Q1 | 585.35 Thousand USD | 11.56% |
2017 Q4 | 1.31 Million USD | 530.28% |
2016 Q2 | 653.11 Thousand USD | 32.19% |
2016 Q4 | 524.7 Thousand USD | -15.55% |
2016 FY | 524.7 Thousand USD | 1230.33% |
2016 Q1 | 494.08 Thousand USD | 1152.67% |
2016 Q3 | 621.35 Thousand USD | -4.86% |
2015 Q4 | 39.44 Thousand USD | 251.13% |
2015 FY | 39.44 Thousand USD | 277.33% |
2015 Q3 | 11.23 Thousand USD | 0.0% |
2015 Q2 | 11.23 Thousand USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 10.45 Thousand USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 60.927% |
Embecta Corp. | 152.1 Million USD | 91.694% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 88.639% |
Dynavax Technologies Corporation | 53.29 Million USD | 76.294% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 80.749% |
Pacira BioSciences, Inc. | 104.35 Million USD | 87.894% |
PainReform Ltd. | - USD | -Infinity% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -86.63% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -120.288% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1460.098% |
Cosmos Health Inc. | 4.78 Million USD | -163.789% |
Journey Medical Corporation | 10.2 Million USD | -23.78% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -120.288% |
Safety Shot Inc | 1.86 Million USD | -575.689% |
Alpha Teknova, Inc. | 11.59 Million USD | -8.962% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -8.466% |
Bright Green Corporation | - USD | -Infinity% |
Procaps Group, S.A. | 96.83 Million USD | 86.954% |
Theratechnologies Inc. | 6.06 Million USD | -108.259% |
Harrow Health, Inc. | 10.86 Million USD | -16.251% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -364.619% |
Biofrontera Inc. | 10.9 Million USD | -15.814% |
DURECT Corporation | 2.21 Million USD | -469.311% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 83.68% |
Cronos Group Inc. | 30.33 Million USD | 58.36% |
OptiNose, Inc. | 8.05 Million USD | -56.893% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1263299900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -121.669% |
Organogenesis Holdings Inc. | 28.25 Million USD | 55.286% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -371.889% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -174.073% |
Radius Health, Inc. | 278.64 Million USD | 95.466% |
Universe Pharmaceuticals INC | 3.34 Million USD | -277.864% |
ProPhase Labs, Inc. | 3.84 Million USD | -228.899% |
Phibro Animal Health Corporation | 265.91 Million USD | 95.249% |
Procaps Group S.A. | 96.83 Million USD | 86.954% |
Alvotech | 74.43 Million USD | 83.028% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.636% |
Rockwell Medical, Inc. | 5.87 Million USD | -115.176% |
SIGA Technologies, Inc. | 64.21 Million USD | 80.328% |
Tilray Brands, Inc. | 252.08 Million USD | 94.989% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 68.401% |
Shineco, Inc. | 1.58 Million USD | -695.266% |
PetIQ, Inc. | 159.3 Million USD | 92.07% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 8368.861% |
Incannex Healthcare Limited | -10.01 Million USD | 226.141% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 67.016% |
Alimera Sciences, Inc. | 1.87 Million USD | -572.326% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 66.478% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -684.468% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -181.798% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4866.739% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -21.705% |
Hempacco Co., Inc. | 2.54 Million USD | -396.848% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 83.028% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 73.568% |
Lantheus Holdings, Inc. | 64.02 Million USD | 80.27% |
Currenc Group, Inc. | 732.91 Thousand USD | -1623.674% |
Kamada Ltd. | 87.74 Million USD | 85.603% |
Indivior PLC | 141.79 Million USD | 91.091% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -2521.825% |
Flora Growth Corp. | 8.5 Million USD | -48.484% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4866.739% |
Evolus, Inc. | 10.99 Million USD | -14.866% |
HUTCHMED (China) Limited | 50.25 Million USD | 74.864% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 88.063% |
Akanda Corp. | 1.28 Million USD | -881.666% |